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by Elsevier B.V. This is an open accesAbstract Background and objectives: Neonatal jaundice is one of the most prevalent clinical
conditions requiring evaluation and management within the first few days of life. Phototherapy
is the single most common intervention used for the treatment of neonatal jaundice. The aim
of our study was to evaluate the efficacy and tolerability of phototherapy with reflectors
compared to conventional phototherapy in controlling neonatal hyperbilirubinaemia.
Patients and methods: In this randomized controlled study, we studied neonates for one year
(from June 2010 to June 2011) who were full term and healthy with uncomplicated jaundice
and who were admitted to the neonatal intensive care unit (NICU) of El-Nasr General Hospital,
Port-Said, Egypt. The subjects were randomized in two groups: group A (n Z 30) received
phototherapy with reflectors and group B (nZ 30) received conventional phototherapy. Serum
bilirubin levels were measured on admission and every 12 h thereafter. With declining read-
ings, bilirubin was measured once daily until hospital discharge.
Results: There was no significant difference in total serum bilirubin on admission between the
two groups. On discharge, bilirubin levels significantly decreased in group A compared to group
B. There was a reduction in the duration of the hospital stay in group A compared to group B.
The only observed complication in the groups was hyperthermia, which was not significantly
different between the two groups.
Conclusion: The present study examined the efficacy and tolerability of phototherapy with re-
flectors in comparison to conventional phototherapy and found that phototherapy with reflec-
tors was significantly better at controlling bilirubin levels in neonates with indirect
hyperbilirubinaemia and at shortening hospitalization time.
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Figure 1 Phototherapy with reflectors.
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Neonatal jaundice is the leading cause of hospital admission
and re-hospitalization in the first week of life worldwide
[1e3]. Appropriate treatment with phototherapy and/or
exchange transfusion is effective in controlling excessive
bilirubin levels in affected infants [4,5]. Severe hyper-
bilirubinaemia may lead to acute bilirubin encephalopathy
(ABE), kernicterus, and a significant risk of mortality in
newborns [6e8]. Survivors may also acquire long-term
neurodevelopmental sequelae, such as cerebral palsy,
sensorineural hearing loss, intellectual difficulties or gross
developmental delays [9e12].
Phototherapy is the single most common intervention
used for the treatment of neonatal jaundice [13].
The greater the surface area exposed, the greater the
effectiveness of phototherapy [14]. Light intensity and the
area of light-exposed skin can also be increased through the
use of reflecting surfaces [15e17].
The purpose of this study was to evaluate the efficacy of
phototherapy with reflectors versus conventional photo-
therapy in controlling neonatal indirect non-haemolytic
hyperbilirubinemia.
2. Patients and methods
This study was carried out in the neonatal intensive care
unit (NICU) of El-Nasr General Hospital, Port-Said, Egypt. A
randomized controlled trial was conducted after obtaining
informed consent from one or both parents of the neonates
in this study. The study duration was one year, from June
2010 to June 2011. This study was approved by the ethics
scientific committee at Cairo University hospital in accor-
dance with the University bylaws for human research.
Full term (37 weeks gestation), healthy newborns
were eligible for enrolment if they met the following
criteria: postnatal age >24 hours (h) and 10 days and had
non-haemolytic indirect hyperbilirubinemia in the first
week of life. We excluded preterm babies, cases with
haemolytic jaundice, including Rh haemolytic disease,
evidence of haemolysis in a peripheral smear, a positive
Coomb’s test, or a glucose-6-phosphate dehydrogenase
(G6PD) deficiency. We also excluded cases requiring
intensive care unit admission, including neonates with
major congenital anomalies, or neonates with clinical or
laboratory evidence of sepsis. The decision to start pho-
totherapy was based on the AAP guidelines for term and
near-term babies [5].
All Participants were subjected to the following:
a) A detailed history and full physical examination on
admission and on a daily basis afterwards. In addition,
neonates had their temperature monitored and poten-
tial side effects recorded, including presence of loose
stools and skin rashes.
b) Clinical investigations including the following: a com-
plete blood count (CBC), and serum bilirubin on admis-
sion and every 12 h thereafter; with declining readings,
bilirubin was measured once daily until hospital
discharge. In addition, a reticulocyte count and
maternal and neonatal blood group tests were collected,and Coombs test were conducted. The rate of bilirubin
decline was calculated and compared in both groups.
c) Randomization process: All eligible neonates were ran-
domized into one of two groups: Group A infants
(n Z 30) received phototherapy with reflectors, and
Group B infants (nZ 30) received phototherapy without
reflectors (conventional phototherapy). Randomization
was conducted using opaque sealed envelopes that were
indistinguishable between groups so that the in-
vestigators were unable to influence group designations.
Each envelope had the assignment of the infant (Group A
or B) with 30 envelopes for each group.
The phototherapy with reflectors unit utilized in the
study consisted of two parallel lamps with an equal length
of fixed stainless steel slices behind each lamp. The fixed
slices allowed for 2 lamps to be used instead of 4 to reduce
the cost of the complete unit. In addition, the slices may
also increase phototherapy efficiency by potentially
enhancing the rate of bilirubin decline, thus reducing the
risk of hyperbilirubinemia complications. The measure-
ments of the phototherapy unit included the following:
height (distance) of the phototherapy from the incubator
was 12 cm; length of 71 cm; width of 25 cm; height from the
ground of 160 cm, and lamp length of 59 cm (Fig. 1). The
sling measurements include the following: a length of
59 cm, a distance from the lamp of 10 cm, and a width of
10 cm. The phototherapy was placed at a distance of 45 cm
from the baby. All babies were naked and wore eye pads
and diapers while receiving phototherapy. The lamps were
changed after every 1000 h of work.
d) Statistical Analysis: Collected data were organized,
tabulated and statistically analyzed using the statisti-
cal package for social sciences (SPSS), version 16 (SPSS
Inc. USA), and ran on an IBM compatible computer using
the Microsoft Windows 7 operating system. For quali-
tative data analyses, the frequency and percent dis-
tributions were calculated; for comparisons between
groups, the Chi square (X2), ManneWhitney or Wilcoxon
tests were used. For quantitative data, the mean and
standard deviations (SD) were calculated; for compar-
isons between two means, the student (t) test was
used. For correlation analyses between two parame-
ters, the bivariate Pearson’s correlation coefficient was
calculated; it was proportional if the sign was positive
and inverse if the sign was negative. The correlation
was considered mild (r < 0.3), moderate (0.3  r  0.7)
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results, a P value  .05 was considered statistically
significant.
3. Results
The details of the flow of the participants are shown in
Fig. 2.
The two groups were comparable with respect to
gender, age, weight, and mode of delivery. The total serum
bilirubin and haemoglobin concentrations at the start of
phototherapy were also similar between groups (Table 1).
All mothers and their neonates were Rh positive. Table 2
shows the outcome variables of the studied neonates with
significant decreases in total serum bilirubin levels in both
groups after discharge compared to their values on admis-
sion. A significant decline in serum bilirubin was observed
after 12 h in group A compared to 24 h in group B (Fig. 3).
The duration of the hospital stay was significantly lower in
group A compared to group B (Fig. 4).
There was a statistically significant moderate, inverse
correlation between the duration of hospitalization and
total bilirubin decrease in group A. The correlation be-
tween the duration of hospitalization and total bilirubinFigure 2 Studydecrease was mild and non-significant in group B (Table
3).
Hyperthermia was the only observed complication in the
two groups. There was no significant difference in the
presence of hyperthermia between the two groups (Table
4).
4. Discussion
The results of the current study suggest that the fixation of
reflective stainless steel slings behind phototherapy lamps
can accelerate the rate of total serum bilirubin decline and
shorten the duration of hospitalization in neonates with
non-haemolytic hyperbilirubinaemia without increasing
phototherapy complications. A study performed by Djoko-
mulijanto et al evaluated the use of white curtains around
the beds of infants treated with phototherapy and reported
a significantly greater rate of bilirubin decline and a
dramatically shorter duration of phototherapy without an
increase in complications in the study group compared to
the control group [16]. Similarly, another study evaluated a
simple and relatively inexpensive method using a fluid bed
to provide high-intensity double-surface (HIDS) photo-
therapy which increased the irradiance of phototherapyflow chart.








Gender Males 15 (50.0%) 13 (43.3%) 28 (46.7%) P Z .60(NS)*
Females 15 (50.0%) 17 (56.7%) 32 (53.3%)
Mode of delivery Normal vaginal delivery 13 (43.3%) 14 (46.7%) 27 (45.0%) P Z .79(NS)*
Cesarean section 17 (56.7%) 16 (53.3%) 33 (55.0%)
Weight 2.93 (0.42) 3.09 (0.35) 3.01 (0.39) P Z .12(NS)*
Age 3.46 (0.89) 3.83 (1.28) 3.65 (1.11) P Z .20(NS)*
TSB on admission 17.88 (2.99) 16.89 (2.71) 17.38 (2.87) P Z .18(NS)*
Haemoglobin concentration 14.76 (1.57) 14.44 (1.79) 14.60 (1.68) P Z .46(NS)*
WBCs count 9.98 (1.29) 9.12 (1.80) 9.55 (1.61) P Z .037(S)*
Platelet count 325.60 (58.92) 331.03 (61.13) 328.32 (59.59) P Z .72(NS)*
Reticulocyte percentage 1.15 (0.44) 1.52 (0.52) 1.33 (0.52) P Z .005(S)*
Maternal blood group
Group A 7 (23.3%) 5 (16.7%) 12 (20.0%) Chi2 Z 1.22#,
P Z .74 (NS)*Group B 4 (13.3%) 6 (20.0%) 10 (16.7%)
Group AB 5 (16.7%) 7 (23.3%) 12 (20.0%)
Group O 14 (46.7%) 12 (40.0%) 26 (43.3%)
Neonatal blood group
Group A 8 (26.7%) 7 (23.3%) 15 (25.0%) Chi2 Z .39#,
P Z .94 (NS)*Group B 5 (16.7%) 6 (20.0%) 11 (18.3%)
Group AB 2 (6.7%) 3 (10.0%) 5 (8.3%)
Group O 15 (50.0%) 14 (46.7%) 29 (48.3%)
All values, except P value*, and Chi2# are expressed in number (%) or mean  SD, S: significant, NS: non-significant.
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cantly more effective in reducing bilirubin than conven-
tional phototherapy [18].
In Hansen’s study, using white pads around the infant’s
bed during phototherapy resulted in an irradiance increase
and thus, shortened the duration of phototherapy [19].
More recently, Babaei et al studied the effect of a white
plastic cover around the phototherapy unit on hyper-
bilirubinemia in full term neonates and observed that the














At 12 h 14.95 (2.98)a 16.88 (2.51) .009(S)
At 24 h 11.65 (2.92)a 14.25 (2.14)b .001(S)
On second day 8.73 (2.06)a 11.36 (2.01)b .001(S)
On discharge 7.26 (0.58)a 8.26 (1.46)b .001(S)
Duration of hospital stay
3.50 (0.51) 4.43 (0.50) .001(S)
S: significant.
a Statistically significant decrease of levels in group A in
comparison to their basal values.
b Statistically significant decrease of levels in group B in
comparison to their basal values.48 h of treatment declined significantly compared to the
control group; in addition, the study group also had a
decreased duration of hospitalization and no increase in
phototherapy complications [20].
Additionally, a study conducted by Salehzadeh et al
showed that the use of a mirror behind phototherapy lamps
can enhance the effectiveness of phototherapy without
increasing the risk of hyperthermia [17].
Sivandan et al studied the effect of a sling application
on the efficacy of phototherapy in healthy full term neo-
nates with non-haemolytic jaundice and found no dramatic
difference in the phototherapy duration between the
study and control groups [21]. Sivandan et al findings are
the opposite of ours, which may be due to Sivandan’s use
of a cover with a low reflection coefficient. In our study,
the neonates with haemolytic jaundice were excluded
because they have rapidly rising serum bilirubin and a
higher potential need for intensive phototherapy or
exchange transfusion. The use of phototherapy with
reflectors in such complex cases should be studied sepa-
rately. Preterm babies were excluded from our study, as
the guidelines for jaundice management are different
from those for term babies. Preterm babies are also more
susceptible to bilirubin encephalopathy due to the imma-
turity of their blood brain barrier and associated
morbidities.
Our study has a few limitations: first, the sample size
was limited, making it difficult to statistically determine
important outcomes; second, we had no access to a photo
radiometer to measure the average irradiance of our
devices.
Figure 3 Total bilirubin concentration in the two groups at different time intervals.
Figure 4 Comparison between group A and group B in regard to the duration of hospitalization.
Table 3 Correlation between duration of hospital stay













r 0.585 0.274 0.038
p 0.001(S) 0.143(NS) 0.772(NS)
n. 30 30 60
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The present study provided evidence for the efficacy and
tolerability of phototherapy with reflectors in controlling
serum bilirubin levels and shortening hospitalization time
compared to conventional phototherapy.Table 4 Incidence of complications in studied groups.
Group A Group B Total




28 (93.3%) 26 (86.7%) 54
(90.0%)
Statistics X2 Z 0.74, p Z 0.38Disclosure
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